Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco.
about
Logistics of community smallpox control through contact tracing and ring vaccination: a stochastic network modelWill HIV vaccination reshape HIV risk behavior networks? A social network analysis of drug users' anticipated risk compensationHIV vaccine acceptability among communities at risk: the impact of vaccine characteristicsEffects of contact network structure on epidemic transmission trees: implications for data required to estimate network structure.Modeling HIV vaccines in Brazil: assessing the impact of a future HIV vaccine on reducing new infections, mortality and number of people receiving ARV.Autonomous targeting of infectious superspreaders using engineered transmissible therapies.Potential impact of tuberculosis vaccines as epidemic control agents.Network effects of risk behavior change following prophylactic interventionsDevelopment of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICESSyphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.Potential public health impact of imperfect HIV type 1 vaccines.Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populationsLive attenuated HIV vaccines: predicting the tradeoff between efficacy and safety.Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban HaitiCircumcision as a primary HIV preventive: extrapolating from the available data.Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.Potential public health impact of new tuberculosis vaccinesAcceptability of PrEP Uptake Among Racially/Ethnically Diverse Young Men Who Have Sex With Men: The P18 StudyBeating the placebo in HIV prevention efficacy trials: the role of the minimal efficacy bound.Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example.Heterogeneity in Number and Type of Sexual Contacts in a Gay Urban Cohort.A combined within-host and between-hosts modelling framework for the evolution of resistance to antimalarial drugsAnticipated changes in sexual risk behaviour following vaccination with a low-efficacy HIV vaccine: survey results from a South African township.What can HIV vaccine trials teach us about future HIV vaccine dissemination?Potential population health outcomes and expenditures of HIV vaccination strategies in the United StatesPredicting the impact of a nonsterilizing vaccine against human immunodeficiency virus.How the circumcision solution in Africa will increase HIV infections.Modelling the influence of human behaviour on the spread of infectious diseases: a reviewA small dose of HIV? HIV vaccine mental models and risk communication.Circumcision of male infants as a human rights violation.HIV and sexually transmitted diseases.The influence of male circumcision for HIV prevention on sexual behaviour among traditionally circumcised men in Cape Town, South Africa.Infection-age structured epidemic models with behavior change or treatment.Imperfect vaccination: some epidemiological and evolutionary consequences.Feedback Between Behavioral Adaptations and Disease DynamicsA modeling study of the Danish HIV epidemic in men who have sex with men: travel, pre-exposure prophylaxis and eliminationEight common misconceptions about HIV vaccines that may impede progress in controlling the AIDS epidemicOn the complexities of modeling HIV/AIDS in Southern Africa
P2860
Q24795843-31983820-E3E4-41BB-B12C-63A6253A3351Q28540319-4FE6D8B5-1A09-412E-830F-5BF51039941DQ30352116-1C9FFD09-B110-4ECC-8BD2-0A3FC287332CQ31161547-81A2BA14-090D-4BA3-A642-F7C6C1D5274AQ33644290-9EC0250E-8459-4233-B319-FFCDBD519F33Q33868991-E9C3A23A-DD1E-439D-A5FE-3C19E91BE429Q33956317-C8C678BF-BE1A-4482-B43E-3D3662256D3BQ34037815-0D2FF298-9610-4C61-AADE-7A7417D55404Q34063486-8FB528EA-83A8-4425-8441-9AD16EE0D35FQ34202159-43DFA85D-F605-4FA5-A1E2-5556965B31C2Q34380779-539F8C12-AFF4-4F5D-B805-68E6A8068FC1Q34380787-8F3BFF28-BE35-46C3-84A5-18B9E07ACCF8Q34598512-EF11E86D-DC9D-4ABE-B568-00D265CE0352Q34758133-E01F1103-7E56-4CC9-A0CE-23901184E367Q35214432-B738E5DC-7F8A-481B-BC3F-721F6BA85AEBQ35575111-8B2F7BCE-5C93-4304-8BB8-15A8B7D94839Q35698044-EB92AE76-8CFC-44F8-A221-526B9FB8930AQ35872932-162E8A2C-15C7-4EF8-9435-B3B541A224DFQ35997359-75685EE7-9219-423E-9B97-5EE9DF6E8CF6Q36487437-FC3225F7-E0AE-4C3F-BC41-698ABE860836Q36603971-B5D49261-C1AA-41FB-83C8-55F5D45AF77AQ36803098-F35CD907-8C5C-404D-921B-CAB3629FBE10Q36921047-329CBE86-1F52-453F-A6ED-2535E189F1D0Q36975561-B94AFC33-99C9-4DC4-8338-291A1C87612DQ37274924-18A39D86-6A55-484A-AAC7-EB13A0B768C6Q37376820-F8EA7492-7F25-483A-A46E-DA61F79C47BFQ37568241-F0352257-36DA-43D7-B7BC-10C1E7FB0C07Q37693125-43E1DC19-C73A-429E-B98D-4AFD2823F1FFQ37760973-72C65733-3FE6-434E-9051-CAA87DD0C5E9Q40151338-590C5E21-4C8A-4849-A957-55D4FECCC197Q45216816-6CDD5F36-A4B3-44D4-8040-278D9AD4E3C0Q49908758-5FB68286-ED06-45CE-A033-72D14C6039AFQ51386981-E18F8CE7-DCEC-4843-BD1F-EB2070AEDEDFQ51925940-943F1933-9BCE-4FB0-ADCF-67913F3D1711Q55110020-5CBDE74E-3AC2-4626-AAD5-6D2157D67FBDQ57093895-E0371F5E-5BDD-42CF-9D1C-E3E3E376B336Q58099099-881F4C87-1C87-4773-BE96-CADF6EF06B68Q58452380-114A83DB-D6D8-41D8-886C-696A41432800Q59006633-155D9C98-7677-4037-AF0D-112F6F6D1AE1
P2860
Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco.
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Prophylactic vaccines, risk be ...... dicating HIV in San Francisco.
@ast
Prophylactic vaccines, risk be ...... dicating HIV in San Francisco.
@en
Prophylactic vaccines, risk be ...... dicating HIV in San Francisco.
@nl
type
label
Prophylactic vaccines, risk be ...... dicating HIV in San Francisco.
@ast
Prophylactic vaccines, risk be ...... dicating HIV in San Francisco.
@en
Prophylactic vaccines, risk be ...... dicating HIV in San Francisco.
@nl
prefLabel
Prophylactic vaccines, risk be ...... dicating HIV in San Francisco.
@ast
Prophylactic vaccines, risk be ...... dicating HIV in San Francisco.
@en
Prophylactic vaccines, risk be ...... dicating HIV in San Francisco.
@nl
P356
P1433
P1476
Prophylactic vaccines, risk be ...... dicating HIV in San Francisco.
@en
P2093
P304
P356
10.1126/SCIENCE.8073289
P407
P577
1994-09-01T00:00:00Z